Good morning :)
Place Order
Add to Watchlist

Veerhealth Care Ltd

VEERHEALTH

Veerhealth Care Ltd

VEERHEALTH
Health CarePharmaceuticals
SmallcapWith a market cap of ₹39 cr, stock is ranked 3,683
High RiskStock is 4.43x as volatile as Nifty
20.003.98% (-0.83)
20.003.98% (-0.83)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹39 cr, stock is ranked 3,683
High RiskStock is 4.43x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹39 cr, stock is ranked 3,683
High RiskStock is 4.43x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
249.481.83
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.276.550.51%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Veerhealth Care is engaged in manufacturing and marketing research-based Ayurvedic medicines. The Company's product categories include Tablets, Syrups, Ointments, Powder, Oil and Toothpaste.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 18.43%, vs industry avg of 9.03%

Constant Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 20.11%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue2.552.645.896.2712.2111.7811.3014.5114.6113.30
Raw Materialssubtract1.581.583.083.848.658.387.9910.448.4011.57
Power & Fuel Costsubtract0.080.080.110.100.220.250.200.200.24
Employee Costsubtract0.470.580.570.470.800.830.880.901.31
Selling & Administrative Expensessubtract0.650.260.460.490.620.480.780.900.72
Operating & Other expensessubtract-0.58-0.221.070.640.760.580.590.331.94
Depreciation/Amortizationsubtract0.210.230.270.320.320.470.520.620.710.73
Interest & Other Itemssubtract0.130.100.070.030.190.220.090.000.01
Taxes & Other Itemssubtract0.020.010.110.220.330.200.31-0.460.880.84
EPS-0.000.010.050.060.150.18-0.030.930.200.08
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Veerhealth Care Ltd99.791.83
Sun Pharmaceutical Industries Ltd45.346.470.75%
Cipla Ltd31.214.800.82%
Torrent Pharmaceuticals Ltd65.3815.800.88%

Price Comparison

Compare VEERHEALTH with any stock or ETF
Compare VEERHEALTH with any stock or ETF
VEERHEALTH
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 2.30%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding30.41%0.00%0.00%0.00%69.59%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

VEERHEALTH has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Veerhealth Care to conduct board meeting

Veerhealth Care will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

16 hours agoCapital Market - Live
Corporate
Veerhealth Care to convene AGM

Veerhealth Care announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Veerhealth Care standalone net profit declines 64.71% in the June 2024 quarter

Net profit of Veerhealth Care declined 64.71% to Rs 0.12 crore in the quarter ended June 2024 as against Rs 0.34 crore during the previous quarter ended June 2023. Sales declined 42.46% to Rs 2.06 crore in the quarter ended June 2024 as against Rs 3.58 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales2.063.58 -42 OPM %-0.9712.01 - PBDT0.340.58 -41 PBT0.150.40 -63 NP0.120.34 -65 Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Veerhealth Care to declare Quarterly Result

Veerhealth Care will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live

Veerhealth Care expects Rs 100 crore revenue in upcoming 2-3 years

3 months agoBusiness Standard

Veerhealth Care secures new export order of Rs 89 lakh

3 months agoBusiness Standard

Stocks that will see action today: April 18, 2023

1 year agoThe Hindu Businessline

Veerhealth Care Standalone December 2020 Net Sales At Rs 3.85 Crore, Up 72.7% Y-o-Y

3 years agoMoneycontrol

Veerhealth Care standalone net profit declines 44.44% in the December 2020 quarter

3 years agoBusiness Standard